• 
• 
• 
• 

CFMOTO Motorcycles

CFMoto was established in China in 1989 as ChungFeng Holding Group Co., ltd., and entered the U.S. market in 2002 as a producer of engines, ATVs and side-by-sides. CFMoto also produced motorcycles for the U.S., mostly with small displacement models, and in 2012, it introduced the 650NK roadster and 650TR tourer in an attempt to break into the middleweight market.

Though it continued to offer its off-road models, CFMoto stopped importing its two-wheeled products to the U.S. after the 2016 model year. Internationally, CFMoto continued to produce motorcycles, while also forming a joint venture with KTM in 2018, with the goal of producing KTM-branded 790 models in China. The arrangement also sees CFMoto introducing the 800MT Touring and 800MT Sport adventure bikes based around KTM’s 799cc Parallel-Twin engine. In 2022, CFMoto became the primary sponsor for a Moto3 team that competes on a KTM RC4 racebike.

After a few years away, CFMoto is now preparing to re-enter the U.S. with a new range of motorcycles. The 800MT models won’t be part of the initial foray, but CFMoto will be introducing seven models covering a few different segments.

Topping the range is the 700CL-X naked bike and its up-spec variant, the 700CL-X Sport. Both models are powered by the same 693cc Parallel-Twin engine claiming a peak output of 73.7 hp at 8500 rpm.

They are joined by the latest iteration of the 650NK and an adventure bike called the 650 ADVentura (known in other markets as the 650MT). Both models are powered by the same 649cc Parallel-Twin, claiming 60.3 hp at 8750 rpm.

For entry-level riders, CFMoto is offering the naked 300NK and the 300SS sportbike (sold in other markets as the 300SR). The two models share the same 292cc Single claiming a newbie-friendly 27.5 hp at 8800 rpm.

Rounding out CFMoto’s U.S. line-up is the Papio mini-bike. Powered by a 126cc Single claiming a modest 9.4 hp at 8500 rpm, the Papio will compete against similar lightweight motorcycles like the Honda Grom and Kawasaki Z125 Pro.